Ming Ni

540 total citations
19 papers, 438 citations indexed

About

Ming Ni is a scholar working on Oncology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Ming Ni has authored 19 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Ophthalmology and 5 papers in Molecular Biology. Recurrent topics in Ming Ni's work include Ocular Diseases and Behçet’s Syndrome (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Ming Ni is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Ming Ni collaborates with scholars based in United States, Australia and China. Ming Ni's co-authors include Anna Fishbein, Sangeeta R. Mehendale, Jing Xie, Han Aung, Chun‐Su Yuan, John A. Duley, Ross Norris, Bruce Charles, Robert B. Nussenblatt and R. B. Nussenblatt and has published in prestigious journals such as Clinical Cancer Research, The FASEB Journal and Annals of Oncology.

In The Last Decade

Ming Ni

18 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Ni United States 10 240 193 97 52 51 19 438
Hong Xin United States 12 105 0.4× 224 1.2× 87 0.9× 21 0.4× 23 0.5× 17 496
Weiwei Liu China 11 82 0.3× 185 1.0× 65 0.7× 27 0.5× 25 0.5× 24 476
Jelena Zarić Switzerland 8 64 0.3× 162 0.8× 90 0.9× 9 0.2× 22 0.4× 15 377
Peiyan Hua China 15 87 0.4× 367 1.9× 41 0.4× 10 0.2× 32 0.6× 31 560
Lan Miao China 15 113 0.5× 269 1.4× 41 0.4× 38 0.7× 3 0.1× 41 481
Li Hou China 12 89 0.4× 129 0.7× 14 0.1× 36 0.7× 6 0.1× 38 377
Peng-Da Guo China 13 140 0.6× 382 2.0× 93 1.0× 12 0.2× 5 0.1× 18 644
Xiangshan Ren China 14 67 0.3× 261 1.4× 61 0.6× 10 0.2× 7 0.1× 31 448
Xueting Shao China 8 100 0.4× 194 1.0× 31 0.3× 15 0.3× 4 0.1× 14 443

Countries citing papers authored by Ming Ni

Since Specialization
Citations

This map shows the geographic impact of Ming Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ni more than expected).

Fields of papers citing papers by Ming Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ni. The network helps show where Ming Ni may publish in the future.

Co-authorship network of co-authors of Ming Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ni. A scholar is included among the top collaborators of Ming Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ni. Ming Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ni, Ming, Lanlan Zhou, You Lü, et al.. (2023). 63P Efficacy and safety of eribulin plus carboplatin combination for HER2-negative metastatic breast cancer. Annals of Oncology. 34. S1490–S1490.
2.
Liu, Ping, Dan Ma, Siyu Zhang, et al.. (2020). Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomedicine & Pharmacotherapy. 130. 110610–110610. 21 indexed citations
3.
Duley, John A., Ming Ni, Catherine Shannon, et al.. (2018). Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients. Therapeutic Drug Monitoring. 40(4). 495–502. 2 indexed citations
4.
Xu, Jian-Ming, Yan Wang, Youliang Wang, et al.. (2017). PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(16). 4602–4616. 64 indexed citations
5.
Woodward, David F., Jenny W. Wang, Ming Ni, et al.. (2016). In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects. The FASEB Journal. 31(1). 368–375. 8 indexed citations
6.
Duley, John A., Ming Ni, Catherine Shannon, et al.. (2015). Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males. European Journal of Pharmaceutical Sciences. 81. 36–41. 19 indexed citations
7.
8.
Moore, Andrew S., Ross Norris, Gareth Price, et al.. (2011). Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited‐sampling, population modelling approach. Journal of Paediatrics and Child Health. 47(12). 875–882. 47 indexed citations
9.
10.
Aung, Han, Ming Ni, Anna Fishbein, et al.. (2007). Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells.. PubMed. 29(3). 175–80. 175 indexed citations
11.
Ni, Ming, et al.. (2005). Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation. Experimental Eye Research. 81(3). 286–297. 15 indexed citations
12.
Chaikin, Margery A., Juan Marugán, Gerald W. De Vries, et al.. (2005). A functional radioreceptor assay of alpha-V-beta-3 (αvβ3) inhibitors in plasma: Application as an ex vivo pharmacodynamic model. Journal of Biochemical and Biophysical Methods. 65(2-3). 107–120. 1 indexed citations
13.
Ni, Ming, et al.. (2003). Distribution of Newly Formed Retinal Pigment Epithelium (RPE) Related Cells in Rabbit Choroidal Neovascularization (CNV). 44(13). 3931–3931. 1 indexed citations
14.
Niesman, Michael R., Ming Ni, & Jeffrey N. Bloom. (1998). Liposome-Encapsulated Clodronate Retards the Development of Experimental Autoimmune Uveitis. Journal of Liposome Research. 8(3). 367–379. 1 indexed citations
15.
Ni, Ming, et al.. (1992). Developmental expression of S-antigen in fetal human and rat eye. Current Eye Research. 11(3). 219–229. 9 indexed citations
16.
Chan, Chi-Chao, et al.. (1991). Injury of Müller cells increases the incidence of experimental autoimmune uveoretinitis. Clinical Immunology and Immunopathology. 59(2). 201–207. 11 indexed citations
17.
Ni, Ming, Chi‐Chao Chan, Robert B. Nussenblatt, & Manabu Mochizuki. (1990). FR900506 (FK506) and 15-Deoxyspergualin (15-DSG) Modulate the Kinetics of Infiltrating Cells in Eyes with Experimental Autoimmune Uveoretinitis. Autoimmunity. 8(1). 43–51. 15 indexed citations
18.
Ni, Ming, et al.. (1989). Immunopharmacological Studies of Qingkaining, A Chinese Blended Medicine: Effects on Experimental Autoimmune Uveoretinitis in the Rat. Immunological Investigations. 18(7). 907–917. 2 indexed citations
19.
Ni, Ming, et al.. (1988). Iris Inflammatory Cells, Fibronectin, Fibrinogen, and Immunoglobulin in Various Ocular Diseases. Archives of Ophthalmology. 106(3). 392–395. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Xin Breakdown of academic impact, for papers by Weiwei Liu Breakdown of academic impact, for papers by Jelena Zarić Breakdown of academic impact, for papers by Peiyan Hua Breakdown of academic impact, for papers by Lan Miao Breakdown of academic impact, for papers by Li Hou Breakdown of academic impact, for papers by Peng-Da Guo Breakdown of academic impact, for papers by Xiangshan Ren Breakdown of academic impact, for papers by Xueting Shao
Rankless by CCL
2026